angiography system News
-
How Does FFRangio Work? - Insights from Dr. Rahul Sharma’s CVIT 2021 Presentation
FFRangio is a non-invasive, angiography-based system that provides quick, wire-free, and drug-free assessment of FFR for multiple vessels. In this video highlight from CVIT Japan 2021, Dr. Rahul P. Sharma, MBBS, FRACP, Director of Structural Interventions at Stanford Medical Center, gives an overview of how FFRangio works. Topics include: 3D model reconstruction – including 3D ...
By CathWorks
-
CathWorks FFRangio System Receives Regulatory Approval in Japan
CathWorks today announced the approval of The CathWorks FFRangio™ System by the Japan’s Ministry of Health, Labour and Welfare (MHLW). The CathWorks FFRangio System is a non-invasive diagnostic technology that is used at the time of a routine angiography. The CathWorks FFRangio System transforms routine angiogram images into objective and comprehensive physiology information, ...
By CathWorks
-
Corindus Named to Fast Company’s “Most Innovative” List for 2021 Amid Global Expansion
Corindus, A Siemens Healthineers Company and one of the leading developers of precision vascular robotics, announced today it has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2021, earning the No. 5 spot in the robotics category. The award recognizes Corindus and its robotic platform with developmental remote technology for its role ...
-
Corindus Named to Fast Company’s “Most Innovative” List for 2021 Amid Global Expansion
Corindus, A Siemens Healthineers Company and one of the leading developers of precision vascular robotics, announced today it has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2021, earning the No. 5 spot in the robotics category. The award recognizes Corindus and its robotic platform with developmental remote technology for its ...
-
FFR-SEARCH Shows Clear Trend Towards Major Adverse Cardiac Events with Lower FFR
Dr. Roberto Diletti from The Erasmus Center in Rotterdam, Netherlands, presented the results of the two-year follow-up analysis of the FFR-SEARCH observational registry during the EuroPCR conference in Paris. The analysis evaluated the outcomes of patients and prognostic value of post-percutaneous coronary intervention (post-PCI) FFR assessment, indicating patients with a lower FFR post-PCI ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you